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Objectives—This study evaluated the diagnostic performance of transvaginal ultra-
sound (TVUS) shear wave elastography (SWE) for evaluating uterine adenomyosis
and leiomyomas.
Methods—Institutional Review Board approval was obtained for prospective enroll-
ment of 34 premenopausal women with pelvic pain and/or bleeding between Janu-
ary 2015 and June 2016. TVUS SWE was performed with regions of interest in
multiple uterine segments and shear wave velocities(SWVs) were recorded. Refer-
ence pelvic magnetic resonance examinations were performed and reviewed without
access to the ultrasound results.
Results—Continuous variables were analyzed using means, t tests, and analysis of
variance. Magnetic resonance imaging revealed adenomyosis in 6 women (12 uter-
ine segments) and leiomyomas in 12 women (28 segments). On a per-patient basis,
mean SWV in 16 women with no adenomyosis or leiomyoma was 4.36 1.7m/s,
compared with 5.76 2.3m/s in 18 women with a magnetic resonance diagnosis of
myometrial pathology (P< .0002; 95% conﬁdence interval,22.2,20.6). On a per-
segment basis, SWV in normal myometrium was 4.86 1.9m/s, compared with
4.96 2.5m/s in adenomyosis and 5.66 2.5m/s in leiomyoma (P5 .34 by one-
way analysis of variance). In pairwise comparison, SWV for adenomyosis and leio-
myoma did not differ signiﬁcantly (P5 .40).
Conclusions—TVUS SWE did not distinguish adenomyosis from leiomyoma.
However, our pilot study demonstrated that myometrial SWVs were higher in uteri
with adenomyosis and leiomyomas than in uteri with myometrium with no abnor-
malities suggesting a potential role for SWE in treatment response assessment.
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U terine adenomyosis, abnormal growth of endometrial tissueinto the myometrium, is a common incidental ﬁnding in hys-terectomy specimens. Estimates of true prevalence range
from 18% to 66% in hysterectomy and biopsy specimens in the
recent literature.1 The primary symptoms of adenomyosis are
chronic pelvic pain and abnormal uterine bleeding, but there is also
an association with subfertility.2 Adenomyosis is underdiagnosed: In
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one recent study, fewer than one quarter of patients had
a correct preoperative diagnosis, with a frequent misdiag-
nosis as leiomyoma by ultrasound.3 The prospective
diagnosis of adenomyosis is clinically signiﬁcant because
it may alter treatment decisions.
B-mode transvaginal ultrasound (TVUS) and pelvic
magnetic resonance have been evaluated for detection of
adenomyosis, with a sensitivity of approximately 74%
and positive predictive value of 68% for TVUS and sen-
sitivity of 81% and positive predictive value of 76% for
magnetic resonance in reader studies with attention to
this diagnosis.4 However, in everyday practice the pro-
spective diagnosis of adenomyosis by conventional
sonography remains uncommon.
Sonoelastography, including static strain elastogra-
phy and dynamic shear wave elastography (SWE), has
been extensively studied in liver ﬁbrosis5–7 and thyroid8
and breast neoplasms9,10 in the past decade; in all instan-
ces, the pathologic condition tends to be ﬁrmer than
normal visceral parenchyma. In contrast, obstetric and
gynecologic implementations are underexplored, with
most of the studies using strain elastography, a subjective
method.11 SWE is an objective quantitative ultrasound
elastography technique, which can depict the stiffness of
anatomic structures to aid in their detection and charac-
terization. SWE uses a push pulse, often referred to as
acoustic radiation force, from the imaging transducer to
generate shear waves in soft tissues. Shear waves propa-
gate perpendicular to the direction of the push pulse,
and their velocity can be tracked by sonography, directly
assessing tissue stiffness. As smooth muscle tumors, leio-
myomas tend to be ﬁrm and rubbery on gross examina-
tion. Adenomyosis is glandular tissue, more similar to
soft endometrium than ﬁrm myometrium.
The application of elastography to the uterus has
been tested in vitro in a study of unﬁxed hysterectomy
specimens,12 distinguishing between leiomyomas (ﬁrmer
than myometrium) and endometrial polyps (softer than
myometrium) and illustrating a single case of adeno-
myosis (similar to endometrium, softer than myome-
trium). TVUS elastography probes enable in vivo
evaluation of this concept. Early reports have focused on
endometrium,13,14 with distinction between normal and
hypertrophic endometrium (relatively soft) versus pol-
yps (slightly ﬁrmer). Assessment of cervical ripening in
labor,15 which is critical to predict the likelihood of suc-
cess in labor induction, has also been explored. Sonoelas-
tographic characterization of benign myometrial
conditions is ongoing. Several recent studies use strain
elastography to diagnose adenomyosis and uterine leio-
myomas.16–18 Only 1 study in the literature investigates
SWE of adenomyosis.19 Thus, the use of in vivo SWE
for myometrial assessment is truly a novel application of
an emerging technology. Therefore, we propose to
assess the test performance of TVUS with SWE to evalu-
ate the marginal diagnostic utility of ultrasound elastog-
raphy for benign uterine pathologies, using pelvic MR as
the reference standard.
Materials and Methods
From January 2015 to June 2016, premenopausal
women with pelvic pain and/or bleeding and no history
of gynecologic malignancy, who provided informed con-
sents, were enrolled in this Institutional Review Board–
approved prospective study. Medical records were re-
viewed for demographic and clinical information.
TVUS was performed on a SuperSonic Aixplorer
(SuperSonic, Aix-en-Provence, France) ultrasound
machine by a registered diagnostic medical sonographer
with 2 years of SWE experience. A 6- to 8-MHz transva-
ginal probe was used to image the uterus, and represen-
tative still and cine gray scale and color Doppler images
were stored. In SWE mode, 2 or 3 regions of interest
(ROIs) (0.5 cm in diameter) were placed in each of
the following segments, depending on the anatomic
location and target tissue thickness, to obtain shear wave
velocities (SWVs): anterior and posterior cervix, anterior
and posterior myometrium, fundus, and within the
endometrial stripe, as well as centered within any visual-
ized myometrial or endometrial mass. The size of the
ROI was carefully chosen in order to measure adequate
soft tissue/lesion yet within the conﬁned uterus/lesion.
The SWV was measured by the SWE software on the
ultrasound machine and shown on the image. The reli-
ability of the measurements was based on the quality of
elasticity color map overlaid on the gray scale image and
the standard deviation of each measurement. The mea-
surement was considered invalid if the color pixels in the
ROI were scant or the standard deviation was greater
than 30%.
Ultrasound images were stored and reviewed using
Syngo Dynamics workstations (Siemens Healthineers,
Mountain View, CA). Ultrasound images were reviewed
in consensus by a board-certiﬁed abdominal radiologist
with 10 years’ experience and a current abdominal
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imaging fellow. Mean values at each uterine anatomic
site were calculated when 2 or more ROIs returned tech-
nically adequate velocities. The SWVs were tabulated.
As the reference standard, contrast enhanced pelvic
MR exams were performed on a 1.5T GE Signa Excite
(GE Healthcare, Waukesha, WI) or Philips Ingenia
(Philips Healthcare, Andover, MA) scanner using an
anterior body surface coil including the following
sequences: 3 plane localizers, sagittal and short-axis T2-
weighted fast spin echo with fat saturation, and pre- and
postcontrast T1-weighted axial spoiled gradient echo
through the pelvis. Patients received 1mg of glucagon
intramuscularly and 0.2mL/kg body weight intravenous
gadobenate dimeglumine (MultiHance, Bracco Diagnos-
tics, Monroe Twp, NJ). MR images were stored and
reviewed using McKesson PACS (McKesson Radiology,
San Francisco, CA).
MR exams were reviewed in consensus by 2 board-
certiﬁed radiologists with 1 and 7 years’ experience after
abdominal fellowship training, who were blinded to the
sonography and clinical ﬁndings. The presence, type,
and location of any uterine pathology were recorded.
Adenomyosis was diagnosed when the uterine junctional
zone thickness exceeded 12mm on T2-weighed image
and/or subendometrial cysts were identiﬁed in an area
of junctional zone irregularity.20 Uterine leiomyomas
were diagnosed when focal, well-circumscribed masses
with low signal on T2-weighted image were identiﬁed
within or arising from the myometrium.21
SWVs were analyzed on a per-patient and a per–
anatomic site basis, recognizing that the multiple meas-
urements within a single uterus are not independent
observations. Continuous variables were analyzed using
means, t tests, and analysis of variance, and categorical
variables were analyzed using counts, frequencies, and
percentages. All statistical tests were performed using
Microsoft Excel (Microsoft Corporation, Redmond,
WA) or SAS 9.4 (SAS Institute, Cary, NC), assuming
P< .05 for statistical signiﬁcance.
Results
Thirty-four premenopausal women (mean age, 36.8
years; range, 22–52) were enrolled, with a mean time
between ultrasound and MR examinations of 11 days
(627; range, 0–118). The studies were performed on
the same day for 25 women, sonography was performed
prior to MR for 4 women, and MR preceded sonogra-
phy for 5 women.
MR revealed adenomyosis in 6 women involving
12 uterine segments, leiomyoma in 12 women involving
28 segments, and no cervical pathology in any of the 34
women. One woman had both adenomyosis and leio-
myomas at MR imaging. On a per-patient basis, mean
SWV in combined segments of 16 women with no
adenomyosis or leiomyoma was 4.36 1.7m/s (range,
1.8–9.4), compared with 5.76 2.3m/s (range 1.7–9.9)
in 18 women with MR diagnosis of myometrial pathol-
ogy (P< .0002; 95% conﬁdence interval of difference,
22.2, 20.6) (Figure 1). Treating each myometrial seg-
ment as an independent observation, SWV in segments
with no abnormalities was 4.86 1.9m/s, compared
with 4.96 2.5m/s in adenomyosis and 5.66 2.5m/s in
leiomyoma (P5 .34 by one-way analysis of variance)
(Figure 2). In pairwise comparison, SWV for adenomyo-
sis and leiomyoma did not differ signiﬁcantly (P5 .40).
Mean cervical stromal SWV was 5.26m/s (61.99;
range, 2.3–10.0), higher than that of normal myome-
trium (P5 .04). Only 1 patient had endometrial pathol-
ogy, diagnosed as a polyp on MR, demonstrating SWV
of 3.6m/s. Representative images in a normal uterine
segment, adenomyosis, and leiomyoma are shown in
Figures 3 through 5.
Discussions
Our pilot study demonstrated that myometrial SWVs
were higher in the setting of uterine pathologies,
Figure 1. Shear wave velocities in normal versus abnormal myometrium
on a per-patient basis.
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including adenomyosis and leiomyomas, than in myo-
metrium with no abnormalities (5.7 versus 4.3m/s;
P< .0002), indicating increased tissue stiffness in
women with myometrial diseases. This observation is
clinically relevant in several regards. Abnormal contrac-
tility and hyperperistalsis, particularly in the inner myo-
metrium or junctional zone, are thought to cause pain
and cramping as well as subfertility due to altered
sperm transport in adenomyosis.21,22 It seems likely
that muscular stiffness, contractility, and propagation of
peristaltic waves are related, suggesting an avenue for
further research into the utility of SWE for treatment
response assessment. Systemic and intrauterine phar-
macologic therapies as well as ablative treatments—
such as high-frequency ultrasound ablation and uterine
artery embolization—for both adenomyosis and leio-
myomas are of increasing interest to women who wish
to avoid surgery and, in some cases, to maintain fertil-
ity. Current methods for assessment of disease severity
and treatment response, such as measurements of uter-
ine size and junctional zone thickness, are purely mor-
phologic. Results of clinical trials have been difﬁcult to
interpret given the poor performance of these imaging
end points, with some investigators reporting decreased
uterine size as a marker of success,23,24 while others
reported unchanged uterine size in patients with symp-
tomatic improvement.25 Decreased junctional zone
thickness is a marker of response in some trials,25,26
although others noted no difference in the junctional
zone/myometrial ratio, suggesting that decreased junc-
tional zone thickness may simply reﬂect overall volume
loss.23 As such, the ﬁeld is ripe for a functional imaging
end point, and with further standardization of the tech-
nique and large-scale validation, we suggest that TVUS
SWE has tremendous potential in this regard.
In contrast to the assumption that tissues with path-
ologic differences may have measurable elasticity dif-
ference, TVUS SWE did not successfully distinguish
adenomyosis from leiomyoma, which may relate to a
few factors. First, adenomyosis is abnormal growth of
glandular tissue into the myometrium. Although glandu-
lar tissue itself is soft, local congestion and reactive mus-
cular hypertrophy may be present within the conﬁned
myometrium in vivo, resulting in increased stiffness. Sec-
ond, although we documented diagnostic SWVs in all
uterine segments, larger and more globular uteri posed
subjective technical challenges, with multiple attempts
required, particularly in the more deeply positioned
Figure 3. 39-year-old woman with a normal uterus. (A) Sagittal T2-
weighted image shows nonenlarged uterus with normal junctional
anatomy and no myometrial masses. (B) Sagittal SWE shows interme-
diate SWV of 3.7m/s in an anterior region of interest.
Figure 2. Shear wave velocities classiﬁed by pathology type when
treating each myometrial segment as an independent observation.
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posterior myometrium. Besides, the generally accepted
assumption is that SWV measurements are most reliable
when they are made in inﬁnite, homogeneous media. In
other words, boundary effects will inﬂuence the meas-
ured speeds, especially within focal masses. However,
clinical applications of SWE in conﬁned tissues have
been carried out over the past decade.27–29 Third, leio-
myomas are often well marginated, whereas adenomyo-
sis is by its nature inﬁltrative. As such, it is much easier
to place a discrete ROI on a sonographically evident
leiomyoma than on an ill-deﬁned region of adenomyo-
sis. In further research, it may be valuable to “work back-
wards” from known areas of abnormality on MRI in
order to more readily isolate the SWV in adenomyosis
and leiomyomas. Finally, adenomyosis and leiomyomas
coexist in up to 57% of women with adenomyosis on
pathologic specimens30 and in 1 woman based on MR
diagnosis in our study population, and it is possible that
some ROIs sampled both conditions at once.
Figure 5. 35-year-old woman with small uterine leiomyomas. (A)
Sagittal T2-weighted image shows small low-signal masses involving
the anterior (arrow) and posterior myometrium. (B) Sagittal SWE with
ROI within the anterior leiomyoma shows focally increased tissue stiff-
ness with SWV 8.6m/s.
Figure 4. 32-year-old woman with adenomyosis and intracavitary
adenomyomatous polyp with subsequent hysteroscopic resection.
(A) Coronal T2-weighted image shows substantial adenomyosis in
the anterior myometrium (the uterus is anteverted), with a markedly
thickened junctional zone (arrows) and tiny high-signal cystic inclu-
sions. Note also the intermediate signal protruding into the canal
within the adenomyomatous polyp. (B) SWE images shows low SWV
of 2.1m/s in adenomyotic segment and (C) stiffened adjacent myo-
metrium with SWV of 9.9m/s.
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This is an emerging area of research, and results
from recent publications regarding sonoelastographic
characterization of adenomyosis and uterine leiomyomas
are inconsistent thus far. In several strain elastography–
based studies,16–18 transvaginal compression was applied
on the targeted uterine segments to obtain strain ratios
among leiomyomas, myometrium with no abnormalities,
and adenomyosis. Their results supported the capability
of strain elastography to differentiate adenomyosis from
leiomyomas, although 1 study showed suboptimal agree-
ment between strain elastography diagnosis of adeno-
myosis and histology.18 Only 1 study in the literature
used SWE to evaluate adenomyosis,19 with results simi-
lar to ours: signiﬁcantly increased myometrial stiffness in
patients with adenomyosis. The above-mentioned in-
consistency might reﬂect underlying technical differen-
ces in measuring tissue stiffness within a conﬁned organ,
which warrants further investigation.
This study has several limitations. First, the sample
size is relatively small in this pilot investigation. Larger
studies with controlled acquisition methods including
number and interquartile range of SWV measurements
will be needed to establish the reliability of this approach
and to establish whether any quantitative threshold sepa-
rates normal from abnormal uteri. Second, there is lack
of pathologic correlation, given the absence of any direct
indication for surgery in this population. We formalized
MRI interpretation and strengthened our standard of
reference by using published criteria, deﬁned anatomic
segments, and 2 experienced readers working in consen-
sus. Third, the phase of menses was not controlled dur-
ing the examination, and hormonal effects on the
myometrium, particularly the junctional zone, may have
contributed to unrecognized SWV variation.
In conclusion, this pilot study demonstrated globally
increased myometrial stiffness using shear wave elastog-
raphy in women with myometrial disorders, including
adenomyosis and leiomyomas. Our result suggests addi-
tional directions for inquiry into ﬁbrosis and/or altered
muscular contractility as a contributor to chronic symp-
toms in women with these disorders, and a potential
role for elastography in treatment response evaluation.
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